Given that REST upregulation is known to induce neuroprotection in various neurological disorders, including Mn-induced toxicity and neurodegenerative diseases, the development of neuroSERMs targeting REST upregulation in a brain neural cell-specific manner absent of peripheral effects might offer a promising approach for novel therapeutic intervention that mitigate these neurological disorders. The gene discussed is REST; the disease is neurodegenerative disease.